BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2014
View Archived Issues
Novel method described for real-time analysis of single-molecule biological processes over time
Read More
Investigators identify novel exon 3 mutation in Shwachman-Bodian-Diamond Syndrome gene
Read More
BioMarin Pharmaceuticals presents new information on BMN-701 for Pompe's disease
Read More
Preliminary results reported from phase Ib study of rhASM
Read More
GL-ONC1 found safe and feasible in phase I trial in head and neck cancer
Read More
Argenta achieves milestone in antibacterial drug discovery collaboration with Antabio
Read More
Zocere licenses neuroprotectant technology for stroke and other brain trauma
Read More
Betagenon begins phase I studies of O-304
Read More
TXNIP as a novel therapeutic target for stroke-induced oxidative injury
Read More
Alcon initiates first-in-human study of LHA-510 for AMD
Read More
Foundation Fighting Blindness provides further support for ReNeuron's ReN-003
Read More
UCB and Sanofi collaborate in immune-mediated diseases
Read More
Caisson expands HEPtune partnership with Novo Nordisk
Read More
NeuroDerm begins enrollment in second phase II study of ND-0612
Read More
U.S. researchers report development of compositions for rare genetic disease
Read More
Roche prepares new cathepsin S and/or L inhibitors
Read More
Rexahn Pharmaceuticals reports data from phase I trial of Supinoxin in solid tumors
Read More
Roche researchers present novel SYK inhibitors
Read More
Sunshine Lake Pharma discloses new compounds for HBV infection
Read More
Aeras begins phase II trial of AERAS-404 vaccine for tuberculosis
Read More
USAN Council selects vepoloxamer as unique non-proprietary name for API in MST-188
Read More
FDA grants orphan drug status to Rebiotix's C. difficile infection treatment
Read More
Innate Pharma continues phase II trial of lirilumab in AML based on DSMB recommendation
Read More
Celsus Therapeutics outlines timeline for MRX-6 atopic dermatitis program
Read More
Chimerix's brincidofovir pilot trial to begin immediately
Read More
